Anaplasma phagocytophilum dihydrolipoamide dehydrogenase 1 affects host-derived immunopathology during microbial colonization

Infection and Immunity

Volumn 80, Issue 9, 2012, Pages 3194-3205

  Chen, Gang ^a   Severo, Maiara S ^a   Sakhon, Olivia S ^a   Choy, Anthony ^a   Herron, Michael J ^b   Felsheim, Roderick F ^b   Wiryawan, Hilda ^c   Liao, Jiayu ^c   Johns, Jennifer L ^d   Munderloh, Ulrike G ^b   Sutterwala, Fayyaz S ^e   Kotsyfakis, Michail ^f   Pedra, Joao H F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c University of California Riverside   (United States)

^d STANFORD UNIVERSITY   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f INSTITUTE OF PARASITOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROLIPOAMIDE DEHYDROGENASE; DIHYDROLIPOAMIDE DEHYDROGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG;

ANAPLASMA PHAGOCYTOPHILUM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; CONTROLLED STUDY; EXTRAMEDULLARY HEMATOPOIESIS; HOST; HUMAN GRANULOCYTIC ANAPLASMOSIS; IMMUNOPATHOLOGY; INFECTION; INFLAMMATION; MACROPHAGE; MICROBIAL COLONIZATION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SPLENOMEGALY; TRANSPOSON;

ADULT; ANAPLASMA PHAGOCYTOPHILUM; ANIMALS; DIHYDROLIPOAMIDE DEHYDROGENASE; EHRLICHIOSIS; FEMALE; GENE DELETION; HUMANS; MACROPHAGES; MICE; MICE, INBRED C57BL; MUTAGENESIS, INSERTIONAL; NEUTROPHILS; SPLEEN; VIRULENCE FACTORS;

EID: 84867600825     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00532-12     Document Type: Article

References (58)

1. Abbas AK, Murphy KM, Sher A. 1996. Functional diversity of helper T lymphocytes. Nature 383:787-793. doi:10.1038/383787a0.
2. Akkoyunlu M, Fikrig E. 2000. Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia. Infect. Immun. 68:1827-1833.
3. Ayres JS, Schneider DS. 2012. Tolerance of infections. Annu. Rev. Immunol. 30:271-294. doi:10.1146/annurev-immunol-020711-075030.
4. + T cells, but is independent of Th1 cytokines and a wide spectrum of effector mechanisms. Eur. J. Immunol. 38:3395-3410.
5. Brodsky IE, Medzhitov R. 2009. Targeting of immune signalling networks by bacterial pathogens. Nat. Cell Biol. 11:521-526.
6. Browning MD, Garyu JW, Dumler JS, Scorpio DG. 2006. Role of reactive nitrogen species in development of hepatic injury in a C57BL/6 mouse model of human granulocytic anaplasmosis. Comp. Med. 56: 55-62.
7. Bussmeyer U, et al. 2010. Impairment of gamma interferon signaling in human neutrophils infected with Anaplasma phagocytophilum. Infect. Immun. 78:358-363.
8. Carlyon JA, et al. 2003. Murine neutrophils require α1,3-fucosylation but not PSGL-1 for productive infection with Anaplasma phagocytophilum. Blood 102:3387-3395. doi:10.1182/blood-2003-02-0621.
9. Carver T, et al. 2008. Artemis and ACT: viewing, annotating and comparing sequences stored in a relational database. Bioinformatics 24:2672-2676. doi:10.1093/bioinformatics/btn529.
10. Choi KS, Garyu J, Park J, Dumler JS. 2003. Diminished adhesion of Anaplasma phagocytophilum-infected neutrophils to endothelial cells is associated with reduced expression of leukocyte surface selectin. Infect. Immun. 71:4586-4594.
11. Choi KS, Scorpio DG, Dumler JS. 2004. Anaplasma phagocytophilum ligation to toll-like receptor (TLR) 2, but not to TLR4, activates macrophages for nuclear factor-k{cyrillic}B nuclear translocation. J. Infect. Dis. 189: 1921-1925.
12. Choi KS, Webb T, Oelke M, Scorpio DG, Dumler JS. 2007. Differential innate immune cell activation and proinflammatory response in Anaplasma phagocytophilum infection. Infect. Immun. 75:3124-3130.
13. Dostert C, et al. 2008. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320:674-677. doi:10.1126/ science.1156995.
14. Dumler JS. 2012. The biological basis of severe outcomes in Anaplasma phagocytophilum infection. FEMS Immunol. Med. Microbiol. 64:13-20.
15. Dumler JS, Barat NC, Barat CE, Bakken JS. 2007. Human granulocytic anaplasmosis and macrophage activation. Clin. Infect. Dis. 45:199-204.
16. Dumler JS, Madigan JE, Pusterla N, Bakken JS. 2007. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin. Infect. Dis. 45(Suppl. 1):S45-S51.
17. Ehlers S. 2004. Adaptive immunity in the absence of innate immune responses? The un-Tolled truth of the silent invaders. Eur. J. Immunol. 34:1783-1788.
18. Eisenbarth SC, Colegio OR, O'Connor W, Sutterwala FS, Flavell RA. 2008. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453:1122-1126. doi: 10.1038/nature06939.
19. Felmet KA, Hall MW, Clark RS, Jaffe R, Carcillo JA. 2005. Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J. Immunol. 174:3765-3772.
20. Felsheim RF, et al. 2006. Transformation of Anaplasma phagocytophilum. BMC Biotechnol. 6:42. doi:10.1186/1472-6750-6-42.
21. Garyu JW, Choi KS, Grab DJ, Dumler JS. 2005. Defective phagocytosis in Anaplasma phagocytophilum-infected neutrophils. Infect. Immun. 73: 1187-1190.
22. Goodman JL, Nelson CM, Klein MB, Hayes SF, Weston BW. 1999. Leukocyte infection by the granulocytic ehrlichiosis agent is linked to expression of a selectin ligand. J. Clin. Invest. 103:407-412. doi:10.1172/ JCI4230.
23. Granick JL, Reneer DV, Carlyon JA, Borjesson DL. 2008. Anaplasma phagocytophilum infects cells of the megakaryocytic lineage through sialylated ligands but fails to alter platelet production. J. Med. Microbiol. 57: 416-423.
24. Herron MJ, Ericson ME, Kurtti TJ, Munderloh UG. 2005. The interactions of Anaplasma phagocytophilum, endothelial cells, and human neutrophils. Ann. N. Y. Acad. Sci. 1063:374-382.
25. Herron MJ, et al. 2000. Intracellular parasitism by the human granulocytic ehrlichiosis bacterium through the P-selectin ligand, PSGL-1. Science 288:1653-1656. doi:10.1126/science.288.5471.1653.
26. Johns JL, Borjesson DL. 2012. Downregulation of CXCL12 signaling and altered hematopoietic stem and progenitor cell trafficking in a murine model of acute Anaplasma phagocytophilum infection. Innate Immun. 18: 418-428. doi:10.1177/1753425911413794.
27. Johns JL, Macnamara KC, Walker NJ, Winslow GM, Borjesson DL. 2009. Infection with Anaplasma phagocytophilum induces multilineage alterations in hematopoietic progenitor cells and peripheral blood cells. Infect. Immun. 77:4070-4080.
28. Lepidi H, et al. 2000. Comparative pathology, and immunohistology associated with clinical illness after Ehrlichia phagocytophila-group infections. Am. J. Trop. Med. Hyg. 62:29-37.
29. Liu B, et al. 2005. Negative regulation of NF-k{cyrillic}B signaling by PIAS1. Mol. Cell. Biol. 25:1113-1123.
30. Luo Y, Dorf ME. 2001. Isolation of mouse neutrophils. Curr. Protoc. Immunol. 22:3.20.1-3.20.6. doi:10.1002/0471142735.im0320s22.
31. Lutz MB, et al. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223:77-92.
32. MacNamara KC, Jones M, Martin O, Winslow GM. 2011. Transient activation of hematopoietic stem and progenitor cells by IFNγ during acute bacterial infection. PLoS One 6:e28669. doi:10.1371/journal. pone.0028669.
33. MacNamara KC, Racine R, Chatterjee M, Borjesson D, Winslow GM. 2009. Diminished hematopoietic activity associated with alterations in innate and adaptive immunity in a mouse model of human monocytic ehrlichiosis. Infect. Immun. 77:4061-4069.
34. Martin ME, Bunnell JE, Dumler JS. 2000. Pathology, immunohistology, and cytokine responses in early phases of human granulocytic ehrlichiosis in a murine model. J. Infect. Dis. 181:374-378.
35. Martin ME, Caspersen K, Dumler JS. 2001. Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis. Am. J. Pathol. 158:1881-1888.
36. Martinon F, Mayor A, Tschopp J. 2009. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27:229-265. doi:10.1146/annurev .immunol.021908.132715.
37. Medzhitov R, Schneider DS, Soares MP. 2012. Disease tolerance as a defense strategy. Science 335:936-941. doi:10.1126/science.1214935.
38. Morgan MJ, Liu ZG. 2011. Crosstalk of reactive oxygen species and NF-k{cyrillic}B signaling. Cell Res. 21:103-115. doi:10.1038/cr.2010.178.
39. Munderloh UG, et al. 2004. Infection of endothelial cells with Anaplasma marginale and A. phagocytophilum. Vet. Microbiol. 101:53-64.
40. Oeckinghaus A, Hayden MS, Ghosh S. 2011. Crosstalk in NF-k{cyrillic}B signaling pathways. Nat. Immunol. 12:695-708.
41. Ojogun N, et al. 2011. Anaplasma phagocytophilum infects mast cells via α1,3-fucosylated but not sialylated glycans and inhibits IgE-mediated cytokine production and histamine release. Infect. Immun. 79:2717-2726.
42. Park J, Choi KS, Grab DJ, Dumler JS. 2003. Divergent interactions of Ehrlichia chaffeensis- and Anaplasma phagocytophilum-infected leukocytes with endothelial cell barriers. Infect. Immun. 71:6728-6733.
43. Pedra JH, et al. 2008. c-Jun NH2-terminal kinase 2 inhibits gamma interferon production during Anaplasma phagocytophilum infection. Infect. Immun. 76:308-316.
44. Pedra JH, et al. 2007. ASC/PYCARD and caspase-1 regulate the IL-18/ IFN-γ axis during Anaplasma phagocytophilum infection. J. Immunol. 179:4783-4791.
45. Pedra JH, et al. 2007. IL-12/23p40-dependent clearance of Anaplasma phagocytophilum in the murine model of human anaplasmosis. FEMS Immunol. Med. Microbiol. 50:401-410.
46. Reneer DV, et al. 2006. Characterization of a sialic acid- and P-selectin glycoprotein ligand-1-independent adhesin activity in the granulocytotropic bacterium Anaplasma phagocytophilum. Cell Microbiol. 8:1972-1984. doi:10.1111/j.1462-5822.2006.00764.x.
47. Rikihisa Y. 2010. Anaplasma phagocytophilum and Ehrlichia chaffeensis: subversive manipulators of host cells. Nat. Rev. Microbiol. 8:328-339.
48. Rikihisa Y. 2011. Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum. Clin. Microbiol. Rev. 24:469-489.
49. Sarkar M, Reneer DV, Carlyon JA. 2007. Sialyl-Lewis x-independent infection of human myeloid cells by Anaplasma phagocytophilum strains HZ and HGE1. Infect. Immun. 75:5720-5725.
50. Schaff UY, et al. 2010. Neutrophils exposed to A. phagocytophilum under shear stress fail to fully activate, polarize, and transmigrate across inflamed endothelium. Am. J. Physiol. Cell Physiol. 299:C87-C96. doi:10.1152/ ajpcell.00165.2009.
51. Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3:1101-1108. doi:10.1038/ nprot.2008.73.
52. Scorpio DG, Von Loewenich FD, Bogdan C, Dumler JS. 2005. Innate immune tissue injury and murine HGA: tissue injury in the murine model of granulocytic anaplasmosis relates to host innate immune response and not pathogen load. Ann. N. Y. Acad. Sci. 1063:425-428.
53. Scorpio DG, von Loewenich FD, Gobel H, Bogdan C, Dumler JS. 2006. Innate immune response to Anaplasma phagocytophilum contributes to hepatic injury. Clin. Vaccine Immunol. 13:806- 809. doi:10.1128/ CVI.00092-06.
54. Sensken SC, Nagarajan M, Bode C, Graler MH. 2011. Local inactivation of sphingosine 1-phosphate in lymph nodes induces lymphopenia. J. Immunol. 186:3432-3440. doi:10.4049/jimmunol.1002169.
55. Sun W, et al. 1997. Immunization against the agent of human granulocytic ehrlichiosis in a murine model. J. Clin. Invest. 100:3014-3018. doi: 10.1172/JCI119855.
56. Thomas RJ, Dumler JS, Carlyon JA. 2009. Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosis. Expert Rev. Anti Infect. Ther. 7:709-722.
57. Ulland TK, et al. 2010. Mutation of Francisella tularensis mviN leads to increased macrophage absent in melanoma 2 inflammasome activation and a loss of virulence. J. Immunol. 185:2670-2674. doi:10.4049/ jimmunol.1001610.
58. von Loewenich FD, Scorpio DG, Reischl U, Dumler JS, Bogdan C. 2004. Control of Anaplasma phagocytophilum, an obligate intracellular pathogen, in the absence of inducible nitric oxide synthase, phagocyte NADPH oxidase, tumor necrosis factor, Toll-like receptor (TLR)2 and TLR4, or the TLR adaptor molecule MyD88. Eur. J. Immunol. 34:1789-1797.